Here are a few of the most interesting Arrowhead Pharmaceuticals statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Arrowhead Pharmaceuticals Facts
- Website: Official Website
- Year Founded: 2004
- Headquarters: Pasadena, CA
- Founder(s): R Bruce Stewart
- Current Chief Executive: Christopher Anzalone
What is Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Our RNAi-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. (source)
Arrowhead Pharmaceuticals Employee Count
Number of Arrowhead Pharmaceuticals employees:
Last updated 10/1/19
Arrowhead Pharmaceuticals Revenue Totals
Arrowhead Pharmaceuticals annual revenue:
- FY 2019: $168 million
- FY 2018: $16 million
- FY 2017: $31 million
- FY 2016: $158,333
- FY 2015: $382,000
Arrowhead Pharmaceuticals annual net income:
- FY 2019: $67 million
- FY 2018: $54 million net loss
- FY 2017: $34 million net loss
- FY 2016: $81 million net loss
- FY 2015: $91 million net loss